278 related articles for article (PubMed ID: 14714889)
1. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
Descamps FJ; Van den Steen PE; Nelissen I; Van Damme J; Opdenakker G
Adv Exp Med Biol; 2003; 535():69-77. PubMed ID: 14714889
[TBL] [Abstract][Full Text] [Related]
2. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
[TBL] [Abstract][Full Text] [Related]
3. Remnant epitopes, autoimmunity and glycosylation.
Opdenakker G; Dillen C; Fiten P; Martens E; Van Aelst I; Van den Steen PE; Nelissen I; Starckx S; Descamps FJ; Hu J; Piccard H; Van Damme J; Wormald MR; Rudd PM; Dwek RA
Biochim Biophys Acta; 2006 Apr; 1760(4):610-5. PubMed ID: 16439062
[TBL] [Abstract][Full Text] [Related]
4. Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Van den Steen PE; Proost P; Brand DD; Kang AH; Van Damme J; Opdenakker G
Biochemistry; 2004 Aug; 43(33):10809-16. PubMed ID: 15311942
[TBL] [Abstract][Full Text] [Related]
5. Chemokines and proteinases in autoimmune diseases and cancer.
Opdenakker G; Van Damme J
Verh K Acad Geneeskd Belg; 2002; 64(2):105-36. PubMed ID: 12085566
[TBL] [Abstract][Full Text] [Related]
6. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Dubois B; Opdenakker G; Carton H
Acta Neurol Belg; 1999 Mar; 99(1):53-6. PubMed ID: 10218093
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase B: a tuner and amplifier of immune functions.
Opdenakker G; Van den Steen PE; Van Damme J
Trends Immunol; 2001 Oct; 22(10):571-9. PubMed ID: 11574282
[TBL] [Abstract][Full Text] [Related]
9. A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys alpha B-crystallin and generates a promiscuous T cell epitope.
Starckx S; Van den Steen PE; Verbeek R; van Noort JM; Opdenakker G
J Neuroimmunol; 2003 Aug; 141(1-2):47-57. PubMed ID: 12965253
[TBL] [Abstract][Full Text] [Related]
10. Stress proteins, autoimmunity, and autoimmune disease.
Winfield JB; Jarjour WN
Curr Top Microbiol Immunol; 1991; 167():161-89. PubMed ID: 2055095
[TBL] [Abstract][Full Text] [Related]
11. Gelatinase B participates in collagen II degradation and releases glycosylated remnant epitopes in rheumatoid arthritis.
Van den Steen PE; Grillet B; Opdenakker G
Adv Exp Med Biol; 2005; 564():45-55. PubMed ID: 16400806
[No Abstract] [Full Text] [Related]
12. On the roles of extracellular matrix remodeling by gelatinase B.
Opdenakker G
Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
14. Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target.
ter Steege J; Vianen M; van Bilsen J; Bijlsma J; Lafeber F; Wauben M
J Rheumatol; 2003 Jun; 30(6):1147-56. PubMed ID: 12784383
[TBL] [Abstract][Full Text] [Related]
15. In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes.
Descamps FJ; Martens E; Ballaux F; Geboes K; Opdenakker G
J Pathol; 2004 Dec; 204(5):555-61. PubMed ID: 15538738
[TBL] [Abstract][Full Text] [Related]
16. Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis.
Lundberg K; Venables PJ
Arthritis Res Ther; 2008; 10(6):122. PubMed ID: 19090965
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of autoimmunity to transaldolase in multiple sclerosis.
Niland B; Perl A
Methods Mol Med; 2004; 102():155-71. PubMed ID: 15286385
[TBL] [Abstract][Full Text] [Related]
18. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J
Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543
[TBL] [Abstract][Full Text] [Related]
19. HLA class II and autoimmunity: epitope selection vs differential expression.
Müller-Hilke B
Acta Histochem; 2009; 111(4):379-81. PubMed ID: 19118870
[TBL] [Abstract][Full Text] [Related]
20. Remnant Epitopes Generating Autoimmunity: From Model to Useful Paradigm.
Opdenakker G; Abu El-Asrar A; Van Damme J
Trends Immunol; 2020 May; 41(5):367-378. PubMed ID: 32299652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
